BMRN
$BMRN
BioMarin Pharmaceutical Inc.
Rare disease biotech company with gene therapy and enzyme replacement treatments.
Healthcare$54.88
+0.35 (+0.64%)
Day Range$53.88 - $55.24
Prev Close$54.53
Analyst Rating
Strong Buy
25 Buy / 6 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Apr 19
Weekly updates
Latest Report
BMRN: Pipeline Recovery & Valuation Upside
BioMarin ($BMRN) trades at $55.83 with a strong buy consensus and a mean analyst target near $88.9. Forward P/E and PEG point to material upside if pipeline and guidance trends improve.
Apr 6, 2026